Common Names: common wormwood, hierba de San Juan, mugwort, artemisia
Methanolic extract of [plant] shows potential in reversing cardiac remodeling in diabetic cardiomyopathy, improving heart function and reducing side effects compared to current anti-hyperglycemic therapies.
Study identifies key pollen allergen components causing allergic asthma/rhinitis & explains cross-reactions. Important for understanding and treating pollen-related allergies.
Artemisa vulgaris extract inhibits lipoxygenases, reducing inflammation. Optimal extraction conditions yield high flavonoid content. Extract acts as a non-competitive inhibitor, potentially binding to free or substrate-bound LOX.
Researchers identified Artemisia vulgaris L. through morpho-anatomy and DNA barcoding. Leaves showed variations, stomata distribution on ventral side. Sequences closely related to other Artemisia species. Study important for exploring A. vulgaris in medicine.
SnO nanoparticles using Artemisia vulgaris as a stabilizing agent inhibit biofilm formation in drug-resistant Candida albicans strains, potentially treating biofilm-related diabetic foot ulcers. They aid in wound healing.
Nanoparticles loaded with Artemisia vulgaris oil showed strong potential in cancer therapy due to their drug delivery capabilities, antitumor and antibacterial properties, and ability to scavenge free radicals.
Researchers tested the extract of Artemisia vulgaris on breast cancer cells, leukemia cells, and fibroblasts. They analyzed its chemical composition and observed its effects. The findings may have implications for potential cancer treatments.
This study analyzed the antidiabetic and anti-inflammatory potential of certain herbs. The extracts from showed high inhibitory activity on α-amylase and LOX, while extracts from showed increased α-amylase inhibition activity and extracts from showed pronounced LOX inhibition activity.
Endophytic fungi from certain plants inhibit the replication of SARS-CoV-2. Stem-based methods are effective for isolating these fungi. This study provides valuable information for developing therapeutic agents against COVID-19.
The study evaluated a vaccine for allergic rhinitis and bronchial asthma, using an ultrashort treatment regimen. The vaccine showed significant reduction in symptoms and immune response polarization, suggesting potential efficacy. Further safety studies are recommended.